APGE Operating Cash Flow Growth

Apogee Therapeutics Inc · Operating Cash Flow Growth

APGE logo

APGE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-10.49%
APGE TTM Cash from Operations YoY % (-355.11% → -10.49%)
High-resolution chart · PNG

APGE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Apogee Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-10.4873%
-24.747%
-32.8765%
-74.5124%
-99.6419%
-96.1759%
-128.9616%
-145.8004%
-166.0875%
-255.1734%
-355.1105%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.